Sorin V. Fedeles
Associate Research Scientist, Yale School of Medicine, New Haven, USA
I am currently a Research Scientist at Yale working on the genetic and molecular mechanism of Autosomal Dominant Polycystic Kidney Disease (ADPKD), the most common monogenic disorder worldwide. I have completed my master?s (Biological and Biomedical Science) and doctorate (Genetics) degrees at Yale University and have continued my post-doctoral training in the same institution. Currently, I am pursuing an MBA for Executives degree at the Yale School of Management. Besides research, I am very interested in the business and management aspect of science and in particular the biotech/pharmaceutical sector. In 2014, I was part of an international team that achieved first place in the Merck-Serono Innovation Cup for designing a novel way to bring a drug-antibody conjugate to market for cancer treatment. During the last two years, Sorin I have been involved in developing novel pharmacological interventions for the treatment of PKD in collaboration with a bioengineering lab at MIT. Recently my efforts have unveiled a new class of drugs which are very effective in slowing down disease progression in orthologous murine models of PKD and based on these findings, I have co-founded a biotech start-up in the New Haven incubator which is now part of the Venture Creation Program (VCP) at the Yale Entrepreneurial Institute (YEI).